RA Capital Management, L.P. reported an acquisition of common shares of Tyra Biosciences Inc. on June 12, 2025. Some of the reporting owners include RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Peter Kolchinsky, and Rajeev M. Shah, among other reporting beneficial owners. The full filing can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tyra Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001415889-25-017446), on June 16, 2025, and is solely responsible for the information contained therein.